Publication

Loss of the RNA polymerase III repressor MAF1 confers obesity resistance

Related publications (50)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Loss of the RNA polymerase III repressor MAF1 confers obesity resistance

Graph Chatbot

Chat with Graph Search

Transcriptomic analysis across liver diseases reveals disease-modulating activation of constitutive androstane receptor in cholestasis

Genome-Scale Identification of Essential Metabolic Processes for Targeting the Plasmodium Liver Stage

In Vitro Human Liver Model of Nonalcoholic Steatohepatitis by Coculturing Hepatocytes, Endothelial Cells, and Kupffer Cells

Investigating the deregulation of metabolic tasks via Minimum Network Enrichment Analysis (MiNEA) as applied to nonalcoholic fatty liver disease using mouse and human omics data

Differential regulation of RNA polymerase III genes during liver regeneration

Interference of silver nanoparticles with essential metal homeostasis in a novel enterohepatic fish in vitro system

Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis

Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease

Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease

PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis